Programm & Abstracts                 "Innovationen in der Augenheilkunde"

Aktuelle Tagungsinformationen
   News and Updates

Anmeldung zur Tagung
   Registration
Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Collateral Events
Rahmenprogramm
   Social program
Jubiläumsparty
   Jubilee Party
DOG Information
   DOG Information
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Ausstellerliste
   Exhibitors
Sponsoren
   Sponsors
Teilnahmegebühren
   Registration fees
Impressum



DOG Homepage

Pseudoexfoliation Syndrome: New Insights Provided by Molecular Biologic Research

Schlötzer-Schrehardt U., Zenkel M., Naumann G. O. H.,
Friedrich-Alexander-Universität, Augenklinik (Erlangen)

Purpose: Pseudoexfoliation (PEX) syndrome is a genetically determined generalized disorder of the extracellular matrix of unknown etiology, which is characterized by the increased production and accumulation of an abnormal extracellular material in intra- and extraocular tissues. Due to deposition of the aberrant matrix product in the trabecular meshwork and in blood vessel walls, PEX syndrome represents a significant risk factor for the development of secondary open-angle glaucoma and for ocular and systemic vascular complications. In order to elucidate the molecular causes of this matrix disorder, we analyzed the gene expression profile in tissues of PEX patients.
Methods: Various experimental approaches for the analysis of differential gene expression in tissues of PEX and control patients comprised cDNA arrays, subtractive hybridization and differential screening, Northern blots, RT-PCR, and in situ hybridization.
Results: The differential gene expression analysis so far showed about 50 differentially expressed genes in PEX tissues, which included matrix components (e.g. fibrillin-1, LTBP-1), matrix-associated enzymes (e.g. transglutaminase-2, matrix metalloproteinases and their inhibitors TIMPs), growth factors (e.g. TGF-ß1), signal transduction molecules (e.g. MAP kinase), cellular stress markers (e.g. heat shock proteins, apolipoprotein D, clusterin), oxidative stress markers (e.g. 8-isoprostane-F2a, glutathione-S-transferase, glutathione peroxidase), and DNA repair proteins (e.g. hmlh1). Based on these findings, we established a pathogenetic concept describing PEX syndrome as a special form of an elastosis accompanied by an increased production of elastic microfibrils by a broad spectrum of potentially elastogenic cells. Overexpression of TGF-ß1, a disbalance of metalloproteinases and TIMPs, excessice cross linking processes, and increased oxidative stress appear to be causally involved in pathogenesis.
Conclusions: The molecular biologic analysis of the gene expression profile in tissues of PEX patients led to a better understanding of the underlying pathogenetic principles and to the identification of disease-related key molecules (e.g. TGF-ß1, TIMP-1) that may be helpful as diagnostic and prognostic parameters or as future therapeutic targets.

Zurück/Back